This study aimed to determine whether the challenge from
Escherichia coli
(
E. coli
) lipopolysaccharide (
LPS
) affects the pharmacokinetics of danofloxacin in broilers. Twenty 1-day-old Arbor Acres (
AA
) broilers were equally and randomly divided into 2 groups. When the chickens were 23, 25, 27, and 29 days old,
E. coli
LPS (1 mL; 0.5 mg/kg body weight [
BW
]) and sterile saline (1 mL) were intraperitoneally injected into the two groups. After the last injection, danofloxacin was given to all chickens by gavage at the dose of 5 mg/kg BW. Then serum and plasma samples at each time point were collected through the wing vein. Danofloxacin concentrations in plasma were detected through the high-performance liquid chromatography (
HPLC
) method and subjected to noncompartmental analysis using Phoenix software. The levels of chicken interleukin-1β (
IL-1β
) and corticosterone (
CORT
) in serum were measured by the Enzyme-linked immunosorbent assay (
ELISA
) kit. In addition, after the collection of plasma or serum samples, 7 chickens (31 days of age) in each group were killed to calculate the organ indices. Compared with the control group, the challenge of LPS significantly decreased the parameters of AUC
0-∞
, C
max
, and t
1/2λz
and increased the parameters of T
max
and λz. Additionally, in the LPS group, the absorption time of danofloxacin was prolonged; however, the elimination was accelerated, which resulted in reduced internal exposure.